Keystone Resort Floorplan

Registered Attendees


Registered attendees (and speakers, organizers, etc.) will have access to the following items from their Account page:

  • Abstracts from speakers and poster sessions, including the joint meeting abstracts, available 30 days prior to the meeting (You can edit your own abstract from My Account page as well)

    NOTE: Abstract authors/submitters may choose to not have their abstract available online and in the secure mobile app until a week before the meeting.

  • Full participant list, including joint meeting participants
  • Printable Invoices and Invitation Letters
  • Scholarship Information
  • Lodging Information

Login to My Account page

Innate and Non-Classical Immune Cells in Cancer Immunotherapy (C5)

Scientific Organizers: Nicholas D. Huntington, Eric Vivier, Caroline Robert and Lewis L. Lanier


March 24—28, 2019

Keystone Resort, Keystone, Colorado, USA


Sponsored by BioLegend, Inc.


Abstract submission is now closed. Registered attendees may bring a poster onsite. Please contact our office at +1 800-253-0685; +1 970-262-1230 or email info@keystonesymposia.org if you are interested.
BEWARE of booking lodging through companies unaffiliated with Keystone Symposia. Click here for more details.

Keystone Symposia is committed to maintaining a positive and respectful environment at its meetings. To this end, please review and comply with our policies.

DEADLINES:
*All deadlines end at 11:59 PM US Mountain Standard Time
Scholarship Deadline: Dec 4, 2018 [details]
Discounted Abstract Deadline: Dec 4, 2018 [details]
Abstract Deadline: Dec 13, 2018 [details]
Discounted Registration Deadline: Jan 23, 2019 [details]

If you have missed a deadline due to the US government shutdown, please contact our office.

Click here to view Cancellation Policy

Register Yourself Deadlines and Fees

Rates and Deadlines listed below are for the 2019-C5 "Innate and Non-Classical Immune Cells in Cancer Immunotherapy" conference only.

*All deadlines end at 11:59 PM US Mountain Standard Time

Deadline Date Cost
Discounted Abstract Deadline
More details
Before and On December 4, 2018 100.00 USD*
- 50.00 USD discount
Abstract Deadline
More details
After December 4, 2018 until February 10, 2019 100.00 USD*
* 50.00 USD of Abstract fee deducted from your registration fee when you register for this meeting
Scholarship
More details
December 4, 2018 n/a
Discounted NON-STUDENT Registration
More details
Before and On January 23, 2019 845.00 USD
(includes 200.00 discount)
Regular NON-STUDENT Registration
More details
After January 23, 2019 1045.00 USD
Discounted STUDENT Registration
More details
Before and On January 23, 2019 620.00 USD
(includes 200.00 discount)
Regular STUDENT Registration
More details
After January 23, 2019 820.00 USD

* Changes in payment type that result in a refund are subject to a processing fee.
* Currency exchange gains/losses are the responsibility of the registrant and the Keystone Symposia will accept no liability for money loss through bank charges, transfers or currency fluctuations.




Discounted Abstract Deadline: December 4, 2018

*All deadlines end at 11:59 PM US Mountain Standard Time

Abstract Submission Fee: 100.00 USD*
Submission by this date receives 50.00 USD discount.
*50.00 USD will be applied to Registration Fee when you register

Abstract Details: It is best to submit your abstract early. Abstract and registration spaces are limited and may fill prior to the abstract or discounted registration deadlines. Submitting an abstract does not constitute or guarantee registration.

Submitting your abstract early allows us to:
  • submit your abstract to organizers to be considered for a short talk
  • accept your abstract online
  • include your abstract on our website and in our secure mobile app
  • reserve your space at the meeting for a poster presentation.**
**Submitting an abstract does not constitute or guarantee registration.
(The Abstract Deadline: is December 13, 2018)

Global Health Travel Award Deadline:

*All deadlines end at 11:59 PM US Mountain Standard Time


Global Health Travel Award Details: You MUST complete your Global Health Travel Award appplication by the Global Health Travel Award Deadline and complete the other required steps (verify your contact information and submit a recommendation letter) to be considered for a travel award.


Click here to learn more about Global Health Travel Awards.

Scholarship Deadline: December 4, 2018

*All deadlines end at 11:59 PM US Mountain Standard Time


Scholarship Details: You MUST submit your abstract by the Scholarship Deadline and complete the other required steps (submit a scholarship application and submit a mentor letter) to be considered for a scholarship.

Click here to learn more about Scholarships.

Abstract Deadline: December 13, 2018

*All deadlines end at 11:59 PM US Mountain Standard Time


Abstract Submission Fee: 100.00 USD*
*50.00 USD will be applied to Registration Fee when you register

Details: It is best to submit your abstract early. Abstract and registration spaces are limited and may fill prior to the abstract or discounted registration deadline. Submitting an abstract does not constitute or guarantee registration.

Submitting your abstract by the Abstract Deadline allows us to:

  • submit your abstract to organizers to be considered for a short talk
  • include your abstract on our website and in our secure mobile app
  • reserve your space at the meeting for a poster presentation.**
**Submitting an abstract does not constitute or guarantee registration.
Abstracts submitted after the Abstract Deadline will NOT be considered for a short talk.

(Discounted Abstract Deadline: is December 4, 2018)

Discounted Registration Deadline: January 23, 2019

*All deadlines end at 11:59 PM US Mountain Standard Time


Registration Fee: 845.00 USD* (includes 200.00 USD discount)
Student Registration Fee: 620.00 USD* (must complete student verification form)

*Includes 50.00 USD of your abstract submission fee

After the Discounted Registration Deadline:


Registration Fee: 1045.00 USD*
Student Registration Fee: 820.00 USD* (must complete student verification form)

*Includes 50.00 USD of your abstract submission fee

Registration spaces are limited and may fill prior to discounted registration deadline.

Please be advised that some meeting participants have received calls and emails from a number of different housing services, including "Exhibitors Housing Services," “Expo Housing Services,” "Global Housing," etc. THESE COMPANIES ARE NOT AFFILIATED WITH KEYSTONE SYMPOSIA and are not authorized by Keystone Symposia to contact you. These companies may tell you that the meeting is filling, without any actual knowledge to that effect, and pressure you into giving them your credit card number to make a lodging reservation with them.

We highly recommend that you not make a reservation with these companies or any other housing service! These companies' representations to participants have been misleading. Please report any calls or correspondence you might have received to Keystone Symposia and book only through lodging links in your Keystone Symposia account, an established travel agency or directly with the hotel(s) listed on our website.
No registration fees are used to fund entertainment or alcohol at this conference

Conference Program    Print  |   View meeting in 24 hr (international) time


The meeting will begin on Sunday, March 24 with registration from 16:00 to 20:00 and a welcome mixer from 18:00 to 20:00. Conference events conclude on Thursday, March 28 with a closing plenary session from 17:00 to 19:30, followed by a social hour and entertainment. We recommend return travel on Friday, March 29 in order to fully experience the meeting.

SUNDAY, MARCH 24

4:00—8:00 PM
Arrival and Registration

Longs Peak Foyer
6:00—8:00 PM
Welcome Mixer
No registration fees are used to fund alcohol served at this function.

Longs Peak Foyer

MONDAY, MARCH 25

7:00—8:00 AM
Breakfast

Longs/Quandary Peaks
8:00—9:00 AM
Welcome and Keynote Address
Registered attendees can view abstracts starting on 02/24/2019

Grays Peak
Ronald Levy, Stanford University, USA
The Immune Response to Cancer

9:00—11:45 AM
Clinical and Industry Advances in Cancer Immunotherapy
Registered attendees can view abstracts starting on 02/24/2019

Grays Peak
Caroline Robert, Institute Gustave Roussy, France
Advances in Melanoma Immunotherapy

Coffee Break

Robert J. Johnston, Bristol-Myers Squibb, USA
VISTA is a pH-Selective PSGL-1 Ligand

Stephan Vagner, Institut Curie, France
Translational Control of Immune Checkpoint and Consequences for Cancer Immunotherapy

Ignacio Melero†, Clinica Universidad de Navarra, Spain
Short Talk: Phase 1b/2 Study of Nivolumab in Combination with an Anti-IL-8 Monoclonal Antibody, BMS-986253, in a Biomarker-Enriched Population of Patients with Advanced Cancer

Michael Wichroski, Bristol-Myers Squibb, USA
Short Talk: Preclinical Characterization of BMS-986299, A First-In-Class NLRP3 Innate Agonist with Potent Antitumor Activity, Alone and in Combination with Checkpoint Blockade

11:45 AM—5:00 PM
On Own for Lunch

11:45 AM—1:00 PM
Poster Setup

Longs/Quandary Peaks
1:00—10:00 PM
Poster Viewing

Longs/Quandary Peaks
2:30—4:30 PM
Workshop 1: Recent Advances in Drugging the Innate Immune Response

Grays Peak
Amit Kumar, Johns Hopkins University, USA
Protein Engineering of s-DAB389-IL2 for Cancer Immunotherapy and Reduced Vascular Leak Syndrome

Andrea Wang-Gillam†, Washington University Siteman Cancer Center, USA
A Randomized Phase 2 Study of Cabiralizumab (cabira) + Nivolumab (nivo) ± Chemotherapy (chemo) in Advanced Pancreatic Ductal Adenocarcinoma (PDAC)

Elizabeth Sturgill, Providence Cancer Institute, USA
Galectin-3 Inhibition with GR-MD-02 Synergizes with T Cell-Targeting Immunotherapy Leading to Reduced Immune Suppression and Improved Overall Survival

Monia Draghi, Compass Therapeutics, USA
Preclinical Characterization of NKp30xBCMA, a Novel Class of NK-Cell Engagers

Brian J. Francica, Aduro Biotech, USA
Magnitude of Therapeutic STING Activation Critically Impacts CD8+ T Cell-Mediated Anti-Tumor Immunity

Carina Hage, Roche Diagnostics GmbH, Germany
Sorafenib Initiates Macrophage-Natural Killer Cell Crosstalk by Macrophage Pyroptosis

4:30—5:00 PM
Coffee Available

Longs Peak Foyer
5:00—7:15 PM
Myeloid Cells
Registered attendees can view abstracts starting on 02/24/2019

Grays Peak
Stefani Spranger, Massachusetts Institute of Technology, USA
Cross-Presenting Dendritic Cell within the Tumor Microenvironment

Dmitry I. Gabrilovich, Wistar Institute, USA
Myeloid-Derived Suppressor Cells in Cancer: Targeting Opportunities

Weiping Zou, University of Michigan, USA
Myeloid Cells in Cancer Immunity and Cancer Stemness

Matthias Ernst†, Olivia Newton-John Cancer Research Institute, Australia
Short Talk: Targeting the Myeloid-Cell Specific Kinase HCK Improves Anti-Tumor Immunity

Katherine Brempelis, Seattle Children's Research Institute, USA
Short Talk: Programming Macrophages to Alter the Solid Tumor Microenvironment

Anje Cauwels†, VIB and Ghent University, Belgium
Short Talk: Specific Targeting of Type I Interferon to the Tumor Microenvironment or to Dendritic Cells as a Novel, Generic, Safe Cancer Immunotherapy

7:15—8:15 PM
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Longs/Quandary Peaks
7:30—10:00 PM
Poster Session 1

Longs/Quandary Peaks

TUESDAY, MARCH 26

7:00—8:00 AM
Breakfast

Longs/Quandary Peaks
8:00—11:30 AM
ADCC and Phagocytosis
Registered attendees can view abstracts starting on 02/24/2019

Grays Peak
Sergio A. Quezada, University College London, UK
Impact of Fc/FcR Interaction on the Activity of Immune Modulatory Antibodies

Mark S. Cragg, University of Southampton, UK
Tumour:Myeloid Interactions Mediating Antibody Immunotherapy

Coffee Break

André Veillette, Institut de Recherches Cliniques de Montreal, Canada
Novel Roles of SLAM Family Receptors in Innate and Innate-Like Immune Cells

Irving L. Weissman, Stanford University, USA
CD47 in Tumor Immunity

Nicholas Wilson†, Gilead Biosciences, USA
Short Talk: Selective FcγR Co-engagement on APCs Modulates the Activity of Therapeutic Antibodies Targeting T Cell Antigens

Darienne R. Myers, Revolution Medicines, USA
Short Talk: Shp1 Loss Drives Robust Anti-Tumor Immunity and Enhances Macrophage Effector Function

11:30 AM—5:00 PM
On Own for Lunch

11:30 AM—1:00 PM
Poster Setup

Longs/Quandary Peaks
1:00—10:00 PM
Poster Viewing

Longs/Quandary Peaks
4:30—5:00 PM
Coffee Available

Longs Peak Foyer
5:00—7:15 PM
Tumor Microenvironment
Registered attendees can view abstracts starting on 02/24/2019

Grays Peak
Maria S. Soengas, Spanish National Cancer Research Centre, Spain
Talk Title to be Announced

Speaker to be Announced

Ursula Grohmann, University of Perugia, Italy
An Intracellular Spatial Dynamics Dictates the Catalytic Versus Signaling Function of IDO1 in Dendritic Cells

Eric D. Frontera, Michigan State University College of Osteopathic Medicine, USA
Short Talk: IgA Fc-Folate Conjugate Activates and Recruits Neutrophils to Directly Target Triple-Negative Breast Cancer Cells

Chelsea Lassiter†, University of Minnesota, USA
Short Talk: Combinatorial Targeting of STAT3 and PD-L1 to Enhance Anti-Tumor Activity in Breast Cancer Models

Ying Jiang†, University of Virginia, USA
Short Talk: Multicellular Immunological Microenvironment Drives Tumor Initiation and Progression in Medulloblastoma

7:15—8:15 PM
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Longs/Quandary Peaks
7:30—10:00 PM
Poster Session 2

Longs/Quandary Peaks

WEDNESDAY, MARCH 27

7:00—8:00 AM
Breakfast

Longs/Quandary Peaks
8:00—11:30 AM
Innate Checkpoints
Registered attendees can view abstracts starting on 02/24/2019

Grays Peak
Carla V. Rothlin, Yale University, USA
Innate Immune Checkpoints in Cancer

Nicholas D. Huntington, Walter and Eliza Hall Institute, WEHI, Australia
Targeting Natural Killer Cells in Cancer Immunotherapy

Coffee Break

Alberto Mantovani, Humanitas University, Italy
New Vistas on Tumor Associated Macrophages and Interaction with NK Cells

Lewis L. Lanier, University of California, San Francisco, USA
NK Cell Memory to Cancer

Dan Fu Ruan, Icahn School of Medicine at Mount Sinai, USA
Short Talk: HLA-E Expression as a Major Determinant of Antitumor Function

Angela L. Tata†, Brown University, USA
Short Talk: KLRG1 as a Novel Target for Immune Checkpoint Blockade

11:30 AM—5:00 PM
On Own for Lunch

11:00 AM—1:00 PM
Poster Setup

Longs/Quandary Peaks
1:00—10:00 PM
Poster Viewing

Longs/Quandary Peaks
4:30—5:00 PM
Coffee Available

Longs Peak Foyer
5:00—7:15 PM
Immune Evasion and Metastasis
Registered attendees can view abstracts starting on 02/24/2019

Grays Peak
Kai W. Wucherpfennig, Dana-Farber Cancer Institute, USA
Targeting Immune Evasion from the MICA - NKG2D Pathway

Ilaria Malanchi, Francis Crick Institute, UK
Neutrophils in the Metastatic Niche

Sohail F. Tavazoie, Rockefeller University, USA
Metastatic Progression as a Model for Understanding Anti-Tumor Immunity

Sumera Rizvi, Mayo Clinic, USA
Short Talk: PD-L1+ Protumor Macrophages Facilitate Tumor Progression in Murine Cholangiocarcinoma

Debolina Ganguly, UT Southwestern Medical Center, USA
Short Talk: Pleiotrophin and Midkine Promote Metastasis in Pre-Clinical Models of Breast Cancer

Hin Ching Lo, Baylor College of Medicine, USA
Short Talk: Circulating Tumor Cell Clusters Exhibit Enhanced Immune Evasion from Natural Killer Cells

7:15—8:15 PM
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Longs/Quandary Peaks
7:30—10:00 PM
Poster Session 3

Longs/Quandary Peaks

THURSDAY, MARCH 28

7:00—8:00 AM
Breakfast

Longs/Quandary Peaks
8:00—11:00 AM
NK Cells and ILCs
Registered attendees can view abstracts starting on 02/24/2019

Grays Peak
Eric Vivier, Centre d'Immunologie de Marseille-Luminy / Innate Pharma, France
Inhibitory NK Cells Receptors in Cancer Prognosis and Therapeutic Intervention

Xiaokui Zhang, Celularity Inc., USA
Adoptive NK Cell Therapies

Coffee Break

David H. Raulet, University of California, Berkeley, USA
Activation and Inhibition of NK Cells in the Tumor Microenvironment, and Applications to Therapy

Adelheid Cerwenka, University of Heidelberg, Germany
Unleashing Potent NK Cell Anti-Tumor Activity in Solid Tumors

Karl-Johan Malmberg, University of Oslo, Norway
Short Talk: Subset Plasticity and Functional Reprogramming during Natural Killer Cell Homeostasis

Robin S. Lindsay, University of Virginia, USA
Short Talk: NK Cells Increase T Cell Infiltration and Antigen Presenting Cell Maturation within Melanoma Tumors

11:00 AM—5:00 PM
On Own for Lunch

2:30—4:30 PM
Workshop 2: Cellular Therapies & Biomarkers

Grays Peak
Chao Guo, Nkarta Therapeutics, USA
Short Talk: NK Cells Engineered to Express a Bispecific CD123/NKG2D Chimeric Antigen Receptor (CAR) and IL-15 As Off-the-Shelf Therapy for Acute Myeloid Leukemia

Xiao-Hua Li, UCSD, USA
Short Talk: Switchable Chimeric Antigen Receptor-Engineered iPSC-Derived Natural Killer Cells

Michael Klichinsky†, Carisma Therapeutics, USA
Human Chimeric Antigen Receptor (CAR) Macrophages for Cancer Immunotherapy

Huang Zhu, UCSD, USA
Deletion of CISH in Human Stem Cell Derived Natural Killer Cells Promotes in vivo Persistence and Enhances Anti-Tumor Activity

Yago Pico de Coaña†, Karolinska Institutet, Sweden
Monitoring Advanced Melanoma Patients after Checkpoint Blockade: NK Cells and MDSCs as Predictive Biomarkers

Richard P. Tobin, University f Colorado Anschutz Medical Campus, USA
Mucosal-Associated Invariant T Cells as a Novel Marker of Response to Anti-PD1 Therapy in Melanoma Patients

4:30—5:00 PM
Coffee Available

Longs Peak Foyer
5:00—7:15 PM
Emerging Techniques in Immunotherapy
Registered attendees can view abstracts starting on 02/24/2019

Grays Peak
Nir Hacohen, Massachusetts General Hospital, USA
Drivers of Successful Immunotherapy

Darrell J. Irvine, Massachusetts Institute of Technology, USA
Combination Immunotherapies Acting through Innate Immunity

Thomas Gebhardt, Doherty Institute for Infection and Immunity, Australia
Imaging Melanoma Immune Homeostasis in the Skin

Bjorn Onfelt, KTH - Royal Institute of Technology, Sweden
Short Talk: Microchip Platform for Imaging-Based Efficacy Testing of Cells and Reagents for Immunotherapy

Davide Bernareggi†, University of California San Diego, USA
Short Talk: Use of CRISPR/Cas9 Screening System to Identify Genes that Regulate NK Cell-Mediated Killing of Glioblastoma and Meningioma

Adam Jelinski, Weizmann institute, Israel
Short Talk: Single-Cell Analysis Illustrates Discrete Cellular Dynamics Generated Between A Pure Checkpoint Blocking Antibody, aCTLA4 mIgG1, and a Dual-Activity aCTLA4 mIgGa2 with Additional FcgR Engaging Activity

7:15—7:30 PM
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)
Registered attendees can view abstracts starting on 02/24/2019

Grays Peak
7:30—8:30 PM
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Longs/Quandary Peaks
8:00—11:00 PM
Entertainment
Entertainment is not subsidized by conference registration fees nor any U.S. federal government grants. Funding for this expense is provided by other revenue sources.

Longs/Quandary Peaks

FRIDAY, MARCH 29

 
Departure


*Session Chair †Invited, not yet responded.



We gratefully acknowledge support for this conference from:


Directors' Fund


These generous unrestricted gifts allow our Directors to schedule meetings in a wide variety of important areas, many of which are in the early stages of research.

Click here to view all of the donors who support the Directors' Fund.



Keystone Symposia thanks our Sponsor for generously supporting this meeting:

BioLegend, Inc.

We gratefully acknowledge additional support for this conference from:

AdipoGen Life Sciences Servier
Innate Pharma oNKo-innate Pty Ltd

We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:



Celularity Inc.


We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:


Click here to view more of these organizations


Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:


Click here to view more of these organizations


If your organization is interested in joining these entities in support of Keystone Symposia, please contact: Sarah Lavicka, Director of Development, Email: sarahl@keystonesymposia.org,
Phone:+1 970-262-2690

Click here for more information on Industry Support and Recognition Opportunities.

If you are interested in becoming an advertising/marketing in-kind partner, please contact:
Yvonne Psaila, Director, Marketing and Communications, Email: yvonnep@keystonesymposia.org,
Phone:+1 970-262-2676